Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nutrien
NTR
|
+$117M |
| 2 |
WP
Worldpay, Inc.
WP
|
+$36.3M |
| 3 |
Becton Dickinson
BDX
|
+$30.5M |
| 4 |
Alibaba
BABA
|
+$29.1M |
| 5 |
NXP Semiconductors
NXPI
|
+$25.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$443M |
| 2 |
Microsoft
MSFT
|
+$315M |
| 3 |
Amazon
AMZN
|
+$275M |
| 4 |
Meta Platforms (Facebook)
META
|
+$191M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.01% |
| 2 | Healthcare | 14.49% |
| 3 | Consumer Discretionary | 11.53% |
| 4 | Industrials | 10.43% |
| 5 | Communication Services | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PMT
1601
PennyMac Mortgage Investment
PMT
$828M
| $2.1M | ﹤0.01% |
116,200
+3,500
| +3% | +$58.6K |
|
|
AFSI
1602
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $2.09M | ﹤0.01% |
169,980
+3,200
| +2% | +$40.1K |
|
1603
Mativ Holdings
MATV
$667M
| $2.09M | ﹤0.01% |
53,400
+1,100
| +2% | +$46.6K |
|
|
INST
1604
DELISTED
Instructure, Inc.
INST
| $2.09M | ﹤0.01% |
49,600
+26,700
| +117% | +$1.05M |
|
1605
Dillards
DDS
$9.59B
| $2.09M | ﹤0.01% |
26,000
+400
| +2% | +$28.9K |
|
1606
Iovance Biotherapeutics
IOVA
$2.95B
| $2.09M | ﹤0.01% |
123,600
+19,000
| +18% | +$288K |
|
1607
SiriusPoint
SPNT
$2.7B
| $2.09M | ﹤0.01% |
149,700
+2,700
| +2% | +$38.3K |
|
1608
Diodes
DIOD
$4.48B
| $2.09M | ﹤0.01% |
68,500
| – | – |
|
1609
Cannae Holdings
CNNE
$675M
| $2.08M | ﹤0.01% |
110,494
+1,900
| +2% | +$34.1K |
|
|
ENDP
1610
DELISTED
Endo International plc
ENDP
| $2.08M | ﹤0.01% |
349,900
+13,100
| +4% | +$91.6K |
|
1611
Piper Sandler
PIPR
$5.54B
| $2.08M | ﹤0.01% |
100,000
| – | – |
|
|
SCS
1612
DELISTED
Steelcase
SCS
| $2.08M | ﹤0.01% |
152,600
| – | – |
|
1613
Antero Midstream
AM
$10.5B
| $2.07M | ﹤0.01% |
129,600
+66,100
| +104% | +$1.28M |
|
|
RWT
1614
Redwood Trust
RWT
$599M
| $2.07M | ﹤0.01% |
133,800
+2,500
| +2% | +$37.5K |
|
|
DVAX
1615
DELISTED
Dynavax Technologies
DVAX
| $2.07M | ﹤0.01% |
104,178
+4,300
| +4% | +$74.3K |
|
|
AAT
1616
American Assets Trust
AAT
$1.41B
| $2.06M | ﹤0.01% |
61,600
+2,800
| +5% | +$95K |
|
|
XOG
1617
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
| $2.06M | ﹤0.01% |
179,500
+7,700
| +4% | +$102K |
|
1618
Fabrinet
FN
$20.3B
| $2.05M | ﹤0.01% |
65,440
| – | – |
|
|
WIRE
1619
DELISTED
Encore Wire Corp
WIRE
| $2.05M | ﹤0.01% |
36,233
+1,700
| +5% | +$88.1K |
|
1620
Houlihan Lokey
HLI
$9.24B
| $2.05M | ﹤0.01% |
46,036
+1,100
| +2% | +$52.1K |
|
|
AIMT
1621
DELISTED
Aimmune Therapeutics
AIMT
| $2.05M | ﹤0.01% |
64,474
+23,900
| +59% | +$841K |
|
1622
Atara Biotherapeutics
ATRA
$76.7M
| $2.05M | ﹤0.01% |
2,104
+960
| +84% | +$875K |
|
|
RDUS
1623
DELISTED
Radius Health, Inc.
RDUS
| $2.05M | ﹤0.01% |
57,000
+3,000
| +6% | +$108K |
|
|
MDC
1624
DELISTED
M.D.C. Holdings, Inc.
MDC
| $2.05M | ﹤0.01% |
85,578
| – | – |
|
|
BMCH
1625
DELISTED
BMC Stock Holdings, Inc
BMCH
| $2.04M | ﹤0.01% |
104,519
+1,900
| +2% | +$40.6K |
|
Similar funds
Swiss National Bank's Q1 2018 Portfolio in Review
As of Q1 2018, Swiss National Bank held 2,520 positions worth $82B, down 11% from $92.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Swiss National Bank withdrew a net $9.58B in Q1 2018, closing 36 positions and reducing 634 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $66.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in Nutrien worth $111M.
- Swiss National Bank's largest Q1 2018 buy was Nutrien: 2,341,052 shares worth $111M.
- Swiss National Bank added most to Worldpay, Inc. in Q1 2018, an estimated $36.3M increase.
- Swiss National Bank's biggest Q1 2018 reduction was Apple, cutting an estimated $443M.
- Swiss National Bank fully exited Potash Corp Of Saskatchewan in Q1 2018, selling an estimated $66.5M.
- Swiss National Bank's ten largest holdings make up 17% of its $82B portfolio in Q1 2018.
- Swiss National Bank opened 6 new positions and closed 36 in Q1 2018.
- Swiss National Bank's portfolio value fell 11% quarter-over-quarter to $82B.
Based on Swiss National Bank's 13F filing for Q1 2018, filed 4 May 2018.